rs1915174

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001330078.2(NRXN1):​c.3364+94665C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.566 in 151,754 control chromosomes in the GnomAD database, including 26,550 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 26550 hom., cov: 31)

Consequence

NRXN1
NM_001330078.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.24

Publications

6 publications found
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]
NRXN1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • chromosome 2p16.3 deletion syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Pitt-Hopkins-like syndrome 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autism
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001330078.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.9 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330078.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1
NM_001330078.2
MANE Select
c.3364+94665C>T
intron
N/ANP_001317007.1Q9ULB1-5
NRXN1
NM_001135659.3
c.3484+94665C>T
intron
N/ANP_001129131.1Q9ULB1-3
NRXN1
NM_001330093.2
c.3361+94665C>T
intron
N/ANP_001317022.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1
ENST00000401669.7
TSL:5 MANE Select
c.3364+94665C>T
intron
N/AENSP00000385017.2Q9ULB1-5
NRXN1
ENST00000404971.5
TSL:1
c.3484+94665C>T
intron
N/AENSP00000385142.1Q9ULB1-3
NRXN1
ENST00000625672.2
TSL:1
c.3340+94665C>T
intron
N/AENSP00000485887.1Q9ULB1-2

Frequencies

GnomAD3 genomes
AF:
0.566
AC:
85778
AN:
151636
Hom.:
26498
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.790
Gnomad AMI
AF:
0.363
Gnomad AMR
AF:
0.568
Gnomad ASJ
AF:
0.393
Gnomad EAS
AF:
0.922
Gnomad SAS
AF:
0.521
Gnomad FIN
AF:
0.443
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.436
Gnomad OTH
AF:
0.549
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.566
AC:
85890
AN:
151754
Hom.:
26550
Cov.:
31
AF XY:
0.565
AC XY:
41926
AN XY:
74148
show subpopulations
African (AFR)
AF:
0.790
AC:
32760
AN:
41456
American (AMR)
AF:
0.569
AC:
8642
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
1363
AN:
3466
East Asian (EAS)
AF:
0.922
AC:
4744
AN:
5144
South Asian (SAS)
AF:
0.521
AC:
2506
AN:
4812
European-Finnish (FIN)
AF:
0.443
AC:
4682
AN:
10566
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.436
AC:
29571
AN:
67804
Other (OTH)
AF:
0.554
AC:
1168
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1701
3403
5104
6806
8507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.449
Hom.:
8372
Bravo
AF:
0.592
Asia WGS
AF:
0.721
AC:
2505
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.098
DANN
Benign
0.36
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1915174;
hg19: chr2-50597915;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.